HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Endotoxin does not alter the pharmacokinetics of micafungin, but it impairs biliary excretion of micafungin via multidrug resistance-associated protein 2 (ABCC2/Mrp2) in rats.

Abstract
Micafungin, a newly developed echinocandin-type antifungal agent, is widely used for the treatment of deep-seated fungal infections including those of Candida species and Aspergillus species. In the present study, the possible alterations in the pharmacokinetics and biliary excretion of micafungin were investigated in endotoxemic rats induced by Klebsiella pneumoniae endotoxin. Endotoxin (2 mg/kg) was injected intraperitoneally 24 h before an intravenous injection of micafungin (1 mg/kg). No significant differences in the plasma concentration-time curves and pharmacokinetic parameters of micafungin were observed between endotoxin-treated and endotoxin-untreated rats. When endotoxin-treated rats received a constant-rate infusion of micafungin, the biliary clearance of micafungin was significantly decreased, whereas the steady-state plasma concentration did not change. By protein immunoblot analysis, a significant decrease in the expression of hepatic multidrug resistance-associated protein 2 (ABCC2/Mrp2), which is an efflux protein for micafungin, was observed in endotoxin-treated rats. These results suggest that endotoxin-induced decrease in the hepatobiliary excretion of micafungin is caused, at least in part, by the reduction of Mrp2-mediated hepatobiliary transport ability. The present study may provide information suggesting that micafungin can be used for patients with endotoxemia without the need for dosage adjustment.
AuthorsTakayuki Noda, Fumie Abe, Jun Ueyama, Miki Kato, Miki Katoh, Masayuki Nadai, Hiroko Saito, Takaaki Hasegawa
JournalJournal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy (J Infect Chemother) Vol. 17 Issue 2 Pg. 207-13 (Apr 2011) ISSN: 1437-7780 [Electronic] Netherlands
PMID20835743 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Echinocandins
  • Endotoxins
  • Lipopeptides
  • Multidrug Resistance-Associated Protein 2
  • Multidrug Resistance-Associated Proteins
  • Micafungin
Topics
  • Animals
  • Biliary Tract (drug effects, metabolism)
  • Biological Transport
  • Echinocandins (chemistry, metabolism, pharmacokinetics)
  • Endotoxemia (drug therapy, microbiology)
  • Endotoxins (administration & dosage, metabolism, pharmacology)
  • Klebsiella pneumoniae (pathogenicity)
  • Lipopeptides (chemistry, metabolism, pharmacokinetics)
  • Male
  • Micafungin
  • Multidrug Resistance-Associated Protein 2
  • Multidrug Resistance-Associated Proteins (metabolism)
  • Rats
  • Rats, Sprague-Dawley

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: